Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Microbot Medical Inc.NASDAQ: MBOT
Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026
Property, plant & equipment (net) rises 348.3% from a year ago
Property, plant & equipment (net) stood at $1.06M at the end of Q1 FY2026, up 348.3% from a year earlier and up 14.3% from the prior quarter. Over 3 fiscal years it compounded at +8.6% a year.
Context
- Property, plant & equipment (net) amounted to 1.4% of total assets at the end of Q1 FY2026, up 0.6 pp from a year earlier.
- Property, plant & equipment (net) increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether property, plant & equipment (net) keeps rising in the next quarterly balance sheet after a +348.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 926K USD
- Year-over-year change
- +336.8%
- 4-year CAGR
- +1.1%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 926K | +336.8% |
| FY2024 | 2024-12-31 | 212K | -47.8% |
| FY2023 | 2023-12-31 | 406K | -43.8% |
| FY2022 | 2022-12-31 | 723K | -18.6% |
| FY2021 | 2021-12-31 | 888K | — |
Property, Plant & Equipment (Net) vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so property, plant & equipment (net) is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +348.3% is the highest of 10, against a peer median of -17.9%.
- Property, plant & equipment (net) amounts to 1.4% of total assets for MBOT, versus a peer median of 20.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $42.01M USD | -8.4% | +3.4% | 20.1% | |
| Mar 2026 | $19.37M USD | +1.2% | +117.3% | 45.7% | |
| Mar 2026 | $11.52M USD | -10.4% | — | 5.1% | |
| Mar 2026 | $10.88M USD | -17.9% | +77.8% | 21.1% | |
| Mar 2026 | $8.58M USD | -18.9% | -15.8% | 39.6% | |
| Mar 2026 | CA$4.67M CAD | -63.4% | -32.7% | 30.9% | |
| Mar 2026 | $1.25M USD | -44.3% | -9.6% | 0.5% | |
| Mar 2026 | $1.06M USD | +348.3% | +8.6% | 1.4% | |
| Mar 2026 | $342.28K USD | +45.9% | +20.8% | 0.6% | |
| Mar 2026 | CA$139.33K CAD | -23.7% | -18.5% | 0.4% | |
| Peer median (excluding MBOT) | — | -17.9% | -3.1% | 20.1% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.